Our News on Newswise

KU Cancer Center pivots to protect patients and trial participants amidst pandemic

The University of Kansas Cancer Center is helping fight the pandemic in numerous ways.
7-May-2020 6:10 PM EDT Add to Favorites

Newswise: ChenNEWFacultyAppointment.jpg

Ronald Chen elected as Fellow to American Society of Clinical Oncology

Ronald Chen, MD, MPH, has been named a Fellow of the American Society of Clinical Oncology (FASCO) in honor of his extraordinary volunteer service, dedication and commitment to ASCO.
28-Apr-2020 9:50 AM EDT Add to Favorites

University of Kansas Medical Center to Participate in Clinical Trial of Hydroxychloroquine in Health Care Workers

KU Medical Center is one of 60 sites across the nation that will be participating in this clinical trial, led by the Duke Clinical Research Institute.
14-Apr-2020 2:05 PM EDT Add to Favorites

Cancer Center Receives Additional $5 Million in Funding from State of Kansas to Support Ongoing Research

The University of Kansas Cancer Center will receive an additional $5 million from the state budget for the KU Cancer Center Research Fund.
31-Mar-2020 5:15 PM EDT Add to Favorites

KU Cancer Center partners with Fox4 to host Teen Town Hall on Vaping

The University of Kansas Cancer Center has partnered with Fox4 and the Kansas City Kansas School district to host a town hall on vaping at Sumner Academy February 27.
25-Feb-2020 3:05 PM EST Add to Favorites

Newswise: SunWeijingOncology2017.jpg

International Society of Gastrointestinal Oncology Appoints Weijing Sun, MD, President-Elect

The International Society of Gastrointestinal Oncology (ISGIO), a not-for-profit global educational organization committed to GI oncology, announces that Weijing Sun, MD, FACP, has been elected the society’s next leader.
5-Dec-2019 9:40 AM EST Add to Favorites

CicloMed Expands Fosciclopirox Phase 1 Trial to Include Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients

First patient enrolled at The University of Kansas Cancer Center in expansion cohort study characterizing the safety, pharmacokinetics and pharmacodynamics of fosciclopirox in bladder cancer patients
4-Dec-2019 12:35 PM EST Add to Favorites

Newswise: RonaldChenHeadshot.jpg

Ronald Chen Named Chair of Radiation Oncology

Ronald Chen, MD, MPH, has been named the Brandmeyer Chair and Professor of Radiation Oncology at the University of Kansas School of Medicine, clinical service chief at The University of Kansas Health System and associate director for Health Equity...
19-Sep-2019 10:05 AM EDT Add to Favorites

See All News

Our Experts on Newswise


Triple-negative breast cancer expert Dr. Priyanka Sharma discusses latest research and clinical trial efforts.
18-Jul-2018 1:35 PM EDT

Newswise: KlempJennifer2008.jpg

Getting Survivorship Care Planning Off the Page and Into Practice

Jennifer Klemp, PhD, MPH, director of cancer survivorship and an associate professor at The University of Kansas Cancer Center, is interviewed by Oncology Nursing News. In this interview, Klemp offers insights on some of the critical issues that...
31-Oct-2016 9:30 AM EDT

Newswise: JChien_Lawrence.jpg

Rewriting the Book on Chemo-Resistant Cancers with a DNA Library

KU Cancer Center researcher is finding out why ovarian cancer is resistant to certain types of chemo to eventually identify a different drug target.
30-Jun-2015 5:05 PM EDT

See All Experts

Our YouTube Videos


The University of Kansas Cancer Center is a world-class, community-based, NCI-designated cancer research and care partnership spanning two states and involving collaboration among researchers, physicians and cancer support professionals. Together, we are working toward a world without cancer. The University of Kansas Cancer Center is transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our nationally accredited patient care program. Our partnership includes cancer research and health care professionals associated with the University of Kansas Medical Center and The University of Kansas Hospital in Kansas City, The University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita, The Stowers Institute for Medical Research and the members of the Midwest Cancer Alliance. Our research programs include Cancer Biology, Cancer Prevention, Cancer Control and Population Health, and Drug Discovery, Delivery and Experimental Therapeutics. Shared resources include Biospecimen, Biostatistics and Informatics, Clinical Research Office and Lead Development and Optimization.

Disease-specific working groups, including both clinicians and basic research investigators, promote collaborative opportunities and the exchange of research ideas. The disease working groups define clinical research priorities respective to their disease specialty with an emphasis on Investigator Initiated Trials (IITs). The cancer center’s current disease working groups include lung, hematology/bone marrow transplant, gastrointestinal, genitor-urinary, head and neck, breast and brain.

Breaking new ground in cancer research requires state-of-the-art facilities. A 82,400-square-foot University of Kansas Clinical Research Center, which opened in January 2012, houses the Phase I clinical trials program. A recently remodeled, 170,000-square-foot Wahl/Hixon research complex, known as The Kansas Masonic Cancer Research Institute, will house 37 cancer-focused researchers. Building a world-class cancer center that is at the forefront of discovery, development and implementation is just the beginning. The legacy of The University of Kansas Cancer Center endures when discoveries made here benefit cancer patients everywhere.



Kay Hawes
Assoc. Dir of News & Media Relations
Health Care



Pauline Horton
Communications Specialist



Natalie Lutz
Executive Director, Marketing & University Relatio



Donna Peck
Assistant Communications Director



Christine Wilson
Director of Public Relations